About Impact Therapeutics Limited
Data last updated:
Impact Therapeutics Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 29 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2010PLC211564. Its GSTIN is 27AAHCM0461F1ZO (Maharashtra).
The company has an authorised share capital of ₹15.1 Cr and a paid-up capital of ₹15.1 Cr. It was formerly known as Miles Tradexim Private Limited. It is led by directors including Ambarish Chatterjee and Pooja Rajan Ambure.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1004 10th Floor Lodha Supremus Powai Saki Vihar Road Opp Mtnl Office Powai, Mumbai, Maharashtra, India – 400072.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,499.49 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹59.3 Cr (net margin 4%) and EBITDA of ₹86.38 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 39% over five years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹128 Cr and satisfied charges of ₹15 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 9 deals on record (6 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹61.58 Cr; the latest was in March 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medecdragon.com.
Company details
Name history
Impact Therapeutics has undergone 2 name changes throughout its history. The company was previously known as Miles Tradexim Private Limited, and Impact Therapeutics Limited. The current legal name is Impact Therapeutics Limited.
| Company Name | Status |
|---|---|
| Impact Therapeutics Limited | Current |
| Miles Tradexim Private Limited | Previous |
CIN history
Impact Therapeutics has one previous CIN (Corporate Identification Number): U51909MH2010PTC211564. The current CIN is U51909MH2010PLC211564, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909MH2010PLC211564 | Current |
| U51909MH2010PTC211564 | Previous |
Contact details
Impact Therapeutics Limited's registered office is in Mumbai, Maharashtra. Its website is medecdragon.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1004 10th Floor Lodha Supremus Powai Saki Vihar Road Opp Mtnl Office Powai, Mumbai, Maharashtra, India – 400072
- IndustryPharma, API Manufacturers
To see the full contact details of Impact Therapeutics Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Impact Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Impact Therapeutics Limited, buy the company report.
Financials of Impact Therapeutics Limited
FY 2024 filings availableImpact Therapeutics Limited reported revenue of ₹1,499.49 Cr (up 75% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 75% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59.3 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Impact Therapeutics Limited, buy the company report.
Board of directors of Impact Therapeutics Limited
Impact Therapeutics has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ambarish Chatterjee | Director | 25 Jan 2024 | 2 Years 9 Months | Current |
| Pooja Rajan Ambure Also directs: Ahimsa Industries Limited | Director | 25 Jan 2024 | 2 Years 9 Months | Current |
| Rakesh Grihpati Singh | Additional Director | 15 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Impact Therapeutics Limited is audited by CHATURVEDI & PATEL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHATURVEDI & PATEL | FY 2023 | 121351W |
Shareholding
The shareholding of Impact Therapeutics Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Impact Therapeutics Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jun 2023 | 100725353 | Axis Bank Limited | ₹20 Cr | Open | |
| 14 Feb 2023 | 100676035 | Axis Bank Limited | ₹20 Cr | Open | |
| 16 Feb 2022 | 100545668 | Axis Bank Limited | ₹88 Cr | Open | |
| 11 Apr 2025 | 101103145 | Hdfc Bank Limited | ₹15 Cr | Satisfied |
To see the full charge records of Impact Therapeutics Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Impact Therapeutics Limited has 9 deals on record (6 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹61.58 Cr; the latest was in March 2024.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Jan 2023 | Rights issue | ₹13.1 Cr | Investors: an individual |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Impact Therapeutics Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Impact Therapeutics Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Union of India Income Tax Department Through Assistant Commissioner of Income Tax | Pending |
To see the full case history of Impact Therapeutics Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Impact Therapeutics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Impact Therapeutics has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Medec Infra Private Limited | U28990MH2021PTC360696 |
To see the full group structure of Impact Therapeutics Limited, buy the company report.
GST
Impact Therapeutics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM0461F1ZO | Maharashtra | Active | 03 Jan 2018 |
To see the full GST registrations and return filing status of Impact Therapeutics Limited, buy the company report.
Recent activity
Impact Therapeutics Limited has 22 board changes on record since 2017: 4 appointments and 18 cessations. The latest: Rakesh Grihpati Singh was appointed as Additional Director on 15 Jul 2025.
20 earlier events are in the company report.
Frequently asked questions
Impact Therapeutics is an active public limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 29 December 2010 (16+ years old) and is registered under CIN U51909MH2010PLC211564.
Impact Therapeutics has 3 current directors:
- Ambarish Chatterjee - Director
- Pooja Rajan Ambure - Director
- Rakesh Grihpati Singh - Additional Director
The latest financial statements of Impact Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Impact Therapeutics is 27AAHCM0461F1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Impact Therapeutics is U51909MH2010PLC211564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Impact Therapeutics has 1 court case on record: 1 filed against it. 1 is pending.
Impact Therapeutics was incorporated on 29 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Impact Therapeutics has 9 deals on record (6 secondary share transfers, 2 rights issues, 1 funding round), with disclosed funding of ₹61.58 Cr; the latest was in March 2024.
Rakesh Grihpati Singh was appointed as Additional Director on 15 Jul 2025. Ambarish Chatterjee ceased to be Additional Director on 29 Sep 2024. Pooja Rajan Ambure ceased to be Additional Director on 29 Sep 2024. Impact Therapeutics has 22 board changes on record in total.
Impact Therapeutics can be reached through the website medecdragon.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
